|
1.
|
|
9 p, 766.8 KB |
Patient satisfaction with remote monitoring of cardiac implantable electronic devices : the V questionnaire
/
Ruiz Díaz, Miguel A. (Universidad Autónoma de Madrid. Departamento de Psicología Social y Metodología) ;
Egea García, Marta (Medtronic Ibérica, S.A. Health Economics & Outcomes Research Department) ;
Muñoz Aguilera, Roberto (Hospital Universitario Infanta Leonor. Department of Cardiology) ;
Viñolas Prat, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Silvestre García, Jorge (Hospital Universitario La Paz. Department of Cardiology) ;
Álvarez Orozco, María (Medtronic Ibérica, S.A. Health Economics & Outcomes Research Department) ;
Martínez Ferrer, José (Hospital Universitario de Araba. Department of Cardiology) ;
Universitat Autònoma de Barcelona
Remote monitoring of cardiac implantable electronic devices (CIEDs) has demonstrated substantial benefits. Treatment guidelines have therefore endorsed its use and is being increasingly adopted in the clinical setting, but the level of satisfaction they convey remains still unknown. [...]
2020 -  10.1186/s12913-020-05216-3
BMC health services research, Vol. 20 (april 2020)
|
|
|
2.
|
|
6 p, 918.0 KB |
Development and Validation of a New High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Coenzyme Q10, Phosphatidylserine, and Vitamin C from a Cutting-Edge Liposomal Vehiculization
/
Ruiz García, Marta (Institut Català de Nanociència i Nanotecnologia) ;
Pérez Lozano, Pilar (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Mercadé Frutós, Débora (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Nardi Ricart, Anna (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Suñé Pou, Marc (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Cano-Sarabia, Mary (Institut Català de Nanociència i Nanotecnologia) ;
García Jimeno, Sonia (Institut Català de Nanociència i Nanotecnologia) ;
Suñé-Negre, Josep Maria (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Maspoch Comamala, Daniel (Institut Català de Nanociència i Nanotecnologia) ;
García Montoya, Encarna (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica)
A high-performance liquid chromatography (HPLC) method was developed to simultaneously quantify three widely used active substances such as coenzyme Q10, phosphatidylserine, and vitamin C. This new method optimizes current timing and costs in the analyses of these three active substances. [...]
2019 - 10.1021/acsomega.9b02456
ACS omega, Vol. 4, Issue 22 (November 2019) , p. 19710-19715
|
|
|
3.
|
|
|
4.
|
|
8 p, 118.8 KB |
Interculturalidad y fronteras internas : una propuesta desde la comunicación y la semiótica
/
Rizo García, Marta (Universitat Autònoma de Barcelona) ;
Romeu Aldaya, Vivian coord (UACM)
Las siguientes páginas presentan una discusión en torno al concepto de frontera, abordado como frontera interna, como frente cultural generador de universos de sentido distintos. En un primer momento se presenta la conceptualización básica de la frontera, distinguiendo entre frontera cultural, interna y simbólica. [...]
The following pages present a discussion around the concept of border, boarded as internal border, as cultural front generator of diferent universes of sense. At a first moment appears the basic conceptualización of the border, distinguishing between cultural, internal and symbolic border. [...]
2009
DeSignis, Núm. 13 (2009) , p. 47-54
|
|
|
5.
|
|
15 p, 3.4 MB |
Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
/
Bogdanov, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Simó-Servat, Olga (Vall d'Hebron Insitut de Recerca) ;
Sampedro, Joel (Vall d'Hebron Insitut de Recerca) ;
Solà-Adell, Cristina (Vall d'Hebron Insitut de Recerca) ;
Garcia-Ramírez, Marta (Vall d'Hebron Insitut de Recerca) ;
Ramos, Hugo (Vall d'Hebron Insitut de Recerca) ;
Guerrero, Marta (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Suñé-Negre, Josep Maria (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Ticó, Josep Ramon (Universitat de Barcelona. Departament de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica) ;
Montoro, Bruno (Vall d'Hebron Insitut de Recerca) ;
Durán, Vicente (Medical Mix S.L.U.) ;
Arias, Luis (Hospital Universitari de Bellvitge) ;
Hernández Pascual, Cristina (Vall d'Hebron Insitut de Recerca) ;
Simó, Rafael (Universitat Autònoma de Barcelona. Departament de Medicina)
Experimental evidence suggests that endothelin 1 (ET-1) is involved in the development of retinal microvascular abnormalities induced by diabetes. The effects of ET-1 are mediated by endothelin A- and B-receptors (ETA and ETB). [...]
2018 - 10.3390/ijms19113578
International journal of molecular sciences, Vol. 19 Núm. 11 (13 2018)
|
|
|
6.
|
|
13 p, 1.6 MB |
Assessing the moderating effect of the end user in consumer behavior : the acceptance of technological implants to increase innate human capacities
/
Pelegrín Borondo, Jorge (Universidad de La Rioja. Departamento de Economía y Empresa) ;
Reinares Lara, Eva (Universidad Rey Juan Carlos. Departamento de Economía y Empresa) ;
Olarte Pascual, Cristina (Universidad de La Rioja. Departamento de Economía y Empresa) ;
Garcia Sierra, Marta (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals)
Today, technological implants are being developed to increase innate human capacities, such as memory or calculation speed, and to endow us with new ones, such as the remote control of machines. This study's aim was two-fold: first, to introduce a Cognitive-Affective-Normative (CAN) model of technology acceptance to explain the intention to use this technology in the field of consumer behavior; and second, to analyze the differences in the intention to use it based on whether the intended implant recipient is oneself or one's child (i. [...]
2016 - 10.3389/fpsyg.2016.00132
Frontiers in psychology, Vol. 7, (February 2016) , Art. 132, p. 1-13
|
|
|
7.
|
|
10 p, 533.9 KB |
Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain : a descriptive analysis
/
Quintero, Javier (Universidad Complutense de Madrid) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Sebastián, Javier San (Hospital Universitario Ramón y Cajal. Madrid) ;
Montañés, Francisco (Hospital Universitario Fundación de Alcorcón. Madrid) ;
Fernández-Jaén, Alberto (Hospital Universitario Quirón. Madrid) ;
Martínez-Raga, José (Universidad de Valencia.) ;
García Giral, Marta
Institut Clínic de Neurociències (Hospital Clínic de Barcelona.) ;
Graell, Montserrat (Hospital Infantil Universitario Niño Jesús. Madrid) ;
Mardomingo, María J. (Hospital Gregorio Marañón (Madrid)) ;
Soutullo, César (Clínica Universidad de Navarra. Departamento de Psiquiatría y Psicología médica) ;
Eiris, Jesús (Complejo Hospitalario Universitario Santiago de Compostela) ;
Téllez, Montserrat (Hospital de La Fe. Valencia) ;
Pamias, Montserrat (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Correas, Javier (Hospital Universitario del Henares. Madrid) ;
Sabaté, Juncal (Shire. Madrid) ;
García-Orti, Laura (Shire. Madrid) ;
Alda, José A. (Hospital de Sant Joan de Déu. Barcelona) ;
Universitat Autònoma de Barcelona.
Departament de Psiquiatria i de Medicina Legal
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition in childhood (5. 3% to 7. 1% worldwide prevalence), with substantial overall financial burden to children/adolescents, their families, and society. [...]
2018 - 10.1186/s12888-017-1581-y
BMC Psychiatry, Vol. 18 (February 2018) , Núm. 40
|
|
|
8.
|
|
17 p, 5.0 MB |
Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
/
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Chiva, Cristina (Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia-Grau, Iolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Diaz, Sherley (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Bijnsdorp, Irene (Department of Urology, VU University Medical Center, Amsterdam, The Netherlands) ;
Campos, Alex (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ;
Di Mauro, Primiano (Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain) ;
Borrós, Salvador (Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain) ;
Reventós, Jaume (IDIBELL-Bellvitge Biomedical Research Institute, Barcelona, Spain) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Paciucci, Rosanna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pegtel, Michiel (Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sabidó, Eduard (Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. [...]
2016 - 10.18632/oncotarget.13634
Oncotarget, Vol. 8 (november 2016) , p. 4960-4976
|
|
|
9.
|
|
14 p, 856.8 KB |
/
Roncero, Carlos (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Szerman, Néstor (Outpatient Mental Health Clinic El Retiro, Gregorio Marañón University Hospital, Madrid, Spain) ;
Terán, Antonio (Outpatient Drug Clinic, Hospital San Juan de Dios, Palencia, Spain) ;
Pino, Carlos (Pontevedra City Council Drug Dependence Service, Galician Health Service (Xunta de Galicia), Pontevedra, Spain) ;
Vázquez, José María (Outpatient Drug Clinic Sants, Barcelona Public Health Agency (ASPB), Barcelona, Spain) ;
Velasco, Elena (Medical Affairs Department, Janssen-Cilag S.A., Madrid, Spain) ;
García-Dorado, Marta (Medical Affairs Department, Janssen-Cilag S.A., Madrid, Spain) ;
Casas, Miguel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal)
There is a need to evaluate the professionals' perception about the consequences of the lack of therapeutic adherence in the evolution of patients with co-occurring disorders. An online survey, released on the Socidrogalcohol [Spanish Scientific Society for Research on Alcohol, Alcoholism and other Drug Addictions] and Sociedad Española de Patología Dual [the Spanish Society of Dual Pathology] web pages, was answered by 250 professionals who work in different types of Spanish health centers where dual diagnosis patients are assisted. [...]
2016 - 10.2147/PPA.S108678
Patient preference and adherence, Vol. 10 (september 2016) , p. 1855-1868
|
|
10.
|
|
30 p, 2.0 MB |
The Present and Future of Prostate Cancer Urine Biomarkers
/
Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colás, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Llauradó, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Cooper, Colin (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ;
Reventós, Jaume (Department of Basic Sciences, International University of Catalonia, 08017 Barcelona, Spain) ;
Clark, Jeremy (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ;
Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca)
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. [...]
2013 - 10.3390/ijms140612620
International journal of molecular sciences, Vol. 14 (june 2013) , p. 12620-12649
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
